Comparison of the nasopharynx microbiome between influenza and non-influenza cases of severe acute respiratory infections: A pilot study

Health Science Reports

Volumn 1, Issue 6, 2018, Pages

  Borges, Luiz Gustavo dos Anjos ^a,b   Giongo, Adriana ^c   Pereira, Leandro de Mattos ^c   Trindade, Fernanda J ^c   Gregianini, Tatiana Schäffer ^d   Campos, Fabrício Souza ^e   Ghedin, Elodie ^f   da Veiga, Ana Beatriz Gorini ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul   (Brazil)

^e UNIVERSITY OF BRASILIA   (Brazil)

^f NEW YORK UNIVERSITY   (United States)

Author keywords

coinfection; influenza A virus; microbiome; respiratory disease; severe acute respiratory infection; upper respiratory tract

Indexed keywords

RNA 16S;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA EXTRACTION; FEMALE; GENE SEQUENCE; HOSPITAL PATIENT; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA A; INFLUENZA A VIRUS; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIOME; NASOPHARYNGEAL ASPIRATION; PHYLOGENY; PILOT STUDY; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; RNA EXTRACTION; VIRUS DETECTION;

EID: 85056884299     PISSN: None     EISSN: 23988835     Source Type: Journal    
DOI: 10.1002/hsr2.47     Document Type: Article

References (38)

1. Taubenberger JK, Kash JC. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe. 2010;7(6):440-451. https://doi.org/10.1016/j.chom.2010.05.009
2. Wong JY, Kelly H, C-MM C, et al. Hospitalization fatality risk of influenza A(H1N1)pdm09: a systematic review and meta-analysis. Am J Epidemiol. 2015;182(4):294-301. https://doi.org/10.1093/aje/kwv054
3. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7(12):887-894. https://doi.org/10.1038/nrmicro2245
4. Wu H, Tremaroli V, Bäckhed F. Linking microbiota to human diseases: a systems biology perspective. Trends Endocrinol Metab. 2015;26(12):758-770. https://doi.org/10.1016/j.tem.2015.09.011
5. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207-214. https://doi.org/10.1038/nature11234
6. Cameron SJS, Huws S, Hegarty MJ, Smith DPM, Mur LAJ. The human salivary microbiome exhibits temporal stability in bacterial diversity. FEMS Microbiol Ecol. 2015;91(July). fiv091. https://doi.org/10.1093/femsec/fiv091
7. Morris A, Beck JM, Schloss PD, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med. 2013;187(10):1067-1075. https://doi.org/10.1164/rccm.201210-1913OC
8. Carmody LA, Zhao J, Kalikin LM, et al. The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation. Microbiome. 2015;3(1):12. https://doi.org/10.1186/s40168-015-0074-9
9. Langevin S, Pichon M, Smith E, et al. Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study. J Gen Virol. 2017;98(10):2425-2437. https://doi.org/10.1099/jgv.0.000920
10. Bosch AATM, Biesbroek G, Trzcinski K, Sanders EAM, Bogaert D. Viral and bacterial interactions in the upper respiratory tract. Hobman TC, ed. PLoS Pathog 2013;9(1):e1003057. https://doi.org/10.1371/journal.ppat.1003057
11. Marsh RL, Kaestli M, Chang AB, et al. The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx. Microbiome. 2016;4(1):37. https://doi.org/10.1186/s40168-016-0182-1
12. Killingley B, Nguyen-Van-Tam J. Routes of influenza transmission. Influenza Other Respi Viruses. 2013;7(SUPPL.2):42-51. https://doi.org/10.1111/irv.12080
13. Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA. 2011;108(13):5354-5359. https://doi.org/10.1073/pnas.1019378108
14. Cauley LS, Vella AT. Why is coinfection with influenza virus and bacteria so difficult to control? Discov Med. 2015;19(102):33-40. https://doi.org/10.1021/ac901991x
15. Bogaert D, Keijser B, Huse S, et al. Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS one. 2011;6(2):e17035. https://doi.org/10.1371/journal.pone.0017035
16. de Steenhuijsen Piters WAA, Sanders EAM, Bogaert D. The role of the local microbial ecosystem in respiratory health and disease. Philos Trans R Soc B Biol Sci. 2015;370(1675):20140294. https://doi.org/10.1098/rstb.2014.0294
17. Short KR, Habets MN, Hermans PW, Diavatopoulos DA. Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? Future Microbiol. 2012;7(5):609-624.
18. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis. 2010;202(8):1287-1295. https://doi.org/10.1086/656333
19. Tarabichi Y, Li K, Hu S, et al. The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles. Microbiome. 2015;3(1):74. https://doi.org/10.1186/s40168-015-0133-2
20. CDC. CDC protocol of realtime RT-PCR for influenza A (H1N1). Vol 1.; 2009.http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/index.html
21. Bates ST, Berg-Lyons D, Caporaso JG, Walters WA, Knight R, Fierer N. Examining the global distribution of dominant archaeal populations in soil. ISME J. 2010;5(5):908-917. https://doi.org/10.1038/ismej.2010.171
22. Salter SJ, Cox MJ, Turek EM, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014;12(1):87. https://doi.org/10.1186/s12915-014-0087-z
23. Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics. 2011;27(6):863-864. https://doi.org/10.1093/bioinformatics/btr026
24. Edgar RC. Supplementary material—search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26(19):2460-2461. https://doi.org/10.1093/bioinformatics/btq461
25. Cole JR, Wang Q, Fish JA, et al. Ribosomal database project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014;42(D1):D633-D642. https://doi.org/10.1093/nar/gkt1244
26. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequences data. Nat Methods. 2010;7(5):335-336. https://doi.org/10.1038/nmeth.f.303
27. DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72(7):5069-5072. https://doi.org/10.1128/AEM.03006-05
28. Vázquez-Baeza Y, Pirrung M, Gonzalez A, Knight R. EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience. 2013;2(1):16. https://doi.org/10.1186/2047-217X-2-16
29. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198(7):962-970. https://doi.org/10.1086/591708
30. Salter SJ, Turner C, Watthanaworawit W, deGoffau MC, Wagner J, Parkhill J, Bentley SD, Goldblatt D, Nosten F, Turner P A longitudinal study of the infant nasopharyngeal microbiota: the effects of age, illness and antibiotic use in a cohort of South East Asian children. Makepeace BL, ed. PLoS Negl Trop Dis 2017;11(10):e0005975.https://doi.org/10.1371/journal.pntd.0005975
31. Lockman JL, Fischer WA, Perl TM, Valsamakis A, Nichols DG. The critically ill child with novel H1N1 influenza A: a case series*. Pediatr Crit Care Med. 2010;11(2):173-178. https://doi.org/10.1097/PCC.0b013e3181ccedae
32. Small C-L, Shaler CR, McCormick S, et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol. 2010;184(4):2048-2056. https://doi.org/10.4049/jimmunol.0902772
33. Leung RKK, Zhou JW, Guan W, Li SK, Yang ZF, Tsui SKW. Modulation of potential respiratory pathogens by pH1N1 viral infection. Clin Microbiol Infect. 2013;19(10):930-935. https://doi.org/10.1111/1469-0691.12054
34. Han MK, Huang YJ, LiPuma JJ, et al. Significance of the microbiome in obstructive lung disease. Thorax. 2012;67(5):456-463. https://doi.org/10.1136/thoraxjnl-2011-201183
35. Zanin M, Baviskar P, Webster R, Webby R. The interaction between respiratory pathogens and mucus. Cell Host Microbe. 2016;19(2):159-168. https://doi.org/10.1016/j.chom.2016.01.001
36. Ehre C, Worthington EN, Liesman RM, et al. Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. PNAS. 2012;109(41):16528-16533. https://doi.org/10.1073/pnas.1206552109
37. Bandoro C, Runstadler JA. Bacterial lipopolysaccharide destabilizes influenza viruses. mSphere. 2017;2(5):e00267-e00217. https://doi.org/10.1128/mSphere.00267-17
38. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol Mech Dis. 2008;3(1):499-522. https://doi.org/10.1146/annurev.pathmechdis.3.121806.154316